STAT3 and acute myeloid leukemia: IL-6 has been reported, by Zhang et al. in a study in 2022, to facilitate chemoresistance in acute myelocytic leukemia (AML) through the uptake of FAs, regulated by stat3/CD36FA uptake [109].